Large-scale testing (Phase 3)Ended earlyNCT04855747
What this trial is testing
Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
Who this might be right for
Major Depressive DisorderDepression
Levomecor Inc. 236